THEONYS Trademark

Trademark Overview


On Tuesday, August 17, 2021, a trademark application was filed for THEONYS with the United States Patent and Trademark Office. The USPTO has given the THEONYS trademark a serial number of 90888056. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, August 23, 2024. This trademark is owned by Theonys, Inc.. The THEONYS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of multi-organ, autoimmune, central nervous system, immunological, inflammatory, metabolic, rare genetic, neurodegenerative, and neurological diseases and disorders

pharmaceutical research and development for others; scientific research for medical purposes in the fields of cancer, multi-organ, autoimmune, central nervous system, immunological, inflammatory, metabolic, rare genetic, neurodegenerative, and neurological diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
theonys

General Information


Serial Number90888056
Word MarkTHEONYS
Filing DateTuesday, August 17, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, August 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements


Description of MarkThe mark consists of an image of a bottom half circle with an underline followed by the wording "Theonys" in stylized font. The letter "T" is capitalized, and the letters "heonys" that follow are lowercase.
Goods and Servicespharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of multi-organ, autoimmune, central nervous system, immunological, inflammatory, metabolic, rare genetic, neurodegenerative, and neurological diseases and disorders
Goods and Servicespharmaceutical research and development for others; scientific research for medical purposes in the fields of cancer, multi-organ, autoimmune, central nervous system, immunological, inflammatory, metabolic, rare genetic, neurodegenerative, and neurological diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTI ASSIGNEE, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressNEW YORK, NY 10022

Party NameTheonys, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameTheonys, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Friday, September 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 10, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 20, 2021NEW APPLICATION ENTERED
Friday, September 10, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 7, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 18, 2022ASSIGNED TO EXAMINER
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, February 23, 2023SOU EXTENSION 1 FILED
Thursday, February 23, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 8, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 13, 2023SOU EXTENSION 1 GRANTED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 21, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 23, 2023SOU EXTENSION 2 FILED
Wednesday, August 23, 2023SOU EXTENSION 2 GRANTED
Wednesday, February 21, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 23, 2024SOU EXTENSION 3 FILED
Friday, February 23, 2024SOU EXTENSION 3 GRANTED
Saturday, February 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 23, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 23, 2024SOU EXTENSION 4 FILED
Friday, August 23, 2024SOU EXTENSION 4 GRANTED
Wednesday, February 21, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 23, 2024SOU TEAS EXTENSION RECEIVED